Hayney MS - Search Results

1

High But Inequitable COVID-19 Vaccine Uptake Among Patients with Inflammatory Bowel Disease.

Schell TL, Richard LJ, Tippins K, Russ RK, Hayney MS, Caldera F. Schell TL, et al. Among authors: hayney ms. Clin Gastroenterol Hepatol. 2022 Jul;20(7):1606-1608.e2. doi: 10.1016/j.cgh.2021.12.013. Epub 2021 Dec 9. Clin Gastroenterol Hepatol. 2022. PMID: 34896281 Free PMC article.

2

Persistence of influenza vaccine-induced antibodies in lung transplant patients between seasons.

Moran JJ, Rose WE, Darga AJ, Rohde KA, Hayney MS. Moran JJ, et al. Among authors: hayney ms. Transpl Infect Dis. 2011 Oct;13(5):466-70. doi: 10.1111/j.1399-3062.2011.00654.x. Epub 2011 May 27. Transpl Infect Dis. 2011. PMID: 21615847

3

Antibody responses to influenza vaccine in pre- and post-lung transplant patients.

Miller RM, Rohde KA, Tingle MT, Moran JJ, Hayney MS. Miller RM, et al. Among authors: hayney ms. Clin Transplant. 2016 May;30(5):606-12. doi: 10.1111/ctr.12726. Epub 2016 Mar 20. Clin Transplant. 2016. PMID: 26928266

4

Vaccination of patients with inflammatory bowel disease.

Caldera F, Saha S, Ley D, Hayney MS. Caldera F, et al. Among authors: hayney ms. J Am Pharm Assoc (2003). 2016 Sep-Oct;56(5):591-3. doi: 10.1016/j.japh.2016.07.005. J Am Pharm Assoc (2003). 2016. PMID: 27594110 No abstract available.

5

Barriers to Administration of Herpes Zoster Immunization in Patients with Inflammatory Bowel Disease.

Caldera F, Hayney MS. Caldera F, et al. Among authors: hayney ms. Inflamm Bowel Dis. 2016 Nov;22(11):E44. doi: 10.1097/MIB.0000000000000942. Inflamm Bowel Dis. 2016. PMID: 27760080 No abstract available.

6

Herpes zoster: The changing landscape.

Caldera F, Ninos CL, Hayney MS. Caldera F, et al. Among authors: hayney ms. J Am Pharm Assoc (2003). 2017 Mar-Apr;57(2):281-283. doi: 10.1016/j.japh.2017.01.007. J Am Pharm Assoc (2003). 2017. PMID: 28285776 Review. No abstract available.

7

Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.

Caldera F, Wasan SK, Farraye FA, Hayney MS. Caldera F, et al. Among authors: hayney ms. Inflamm Bowel Dis. 2017 Oct;23(10):E50-E51. doi: 10.1097/MIB.0000000000001239. Inflamm Bowel Dis. 2017. PMID: 28906295 No abstract available.

8

Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients.

Caldera F, Saha S, Wald A, Garmoe CA, McCrone S, Megna B, Ley D, Reichelderfer M, Hayney MS. Caldera F, et al. Among authors: hayney ms. Dig Dis Sci. 2018 Jun;63(6):1532-1540. doi: 10.1007/s10620-018-5043-2. Epub 2018 Mar 29. Dig Dis Sci. 2018. PMID: 29594970

9

Immunosuppression Does Not Affect Antibody Concentrations to Measles, Mumps, and Rubella in Patients with Inflammatory Bowel Disease.

Caldera F, Misch EA, Saha S, Wald A, Zhang Y, Hubers J, Megna B, Ley D, Reichelderfer M, Hayney MS. Caldera F, et al. Among authors: hayney ms. Dig Dis Sci. 2019 Jan;64(1):189-195. doi: 10.1007/s10620-018-5321-z. Epub 2018 Oct 13. Dig Dis Sci. 2019. PMID: 30317494

10

Using Number Needed to Harm to Put the Risk of Herpes Zoster From Tofacitinib in Perspective.

Caldera F, Hayney MS, Cross RK. Caldera F, et al. Among authors: hayney ms. Inflamm Bowel Dis. 2019 May 4;25(6):955-957. doi: 10.1093/ibd/izy387. Inflamm Bowel Dis. 2019. PMID: 30605536 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

180 results

Search Page